India becomes the largest supplier of drugs to Russia

4 June 2024
russia_pharmacy_big

India has become the largest supplier of drugs to the Russian market, overtaking Germany, which had been in the lead for the last two years, reports The Pharma Letter’s Russia correspondent.

According to data of the Russian pharma analytics agency RNC Pharma, in 2023, some 293.9 million packages of Indian drugs were supplied to the Russian market, which is almost 3% higher than a year earlier. The increase in supplies came after three years of decline.

As for Germany, in 2023 it reduced its supplies by 20%, to 238.7 million packages. Other key supplying countries include France - 149.3 million packages, Hungary (112.5 million packages - +11.6%) and Belarus. The UK reduced its drug supplies to Russia last year by 10.5%, to 63.2 million packages, while in case of Poland the decline was 16.5%, to 60.9 million.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Generics